Brighthouse Financial

BHF · NASDAQ

$47.64+$0.04 (+0.08%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $47.60

BHF analyst rating

HoldConsensus of 4 analysts over the last 12 months. 0% rate it a buy.

Strong buy0
Buy0
Hold4
Underperform0
Sell0

12-month price target · 7 analysts

Average $66.71 (+40.0% upside)

Low: $55.55
Now: $47.64
High: $73.50

Upgrades and downgrades

The latest rating actions, newest first

BHF analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
JP Morgan	Oct 15, 2026	Upgrade	Underweight → Neutral	$63.00 → $55.00	81%
Keefe, Bruyette & Woods	Oct 15, 2026	Maintains	Market Perform	$57.00 → $55.00	71%
Keefe, Bruyette & Woods	Oct 9, 2026	Maintains	Market Perform	$67.00 → $57.00	71%
Keefe, Bruyette & Woods	Mar 26, 2026	Initiates	Market Perform	$67.00	71%
Barclays	Jan 8, 2026	Downgrade	Overweight → Equal-Weight	$65.00	61%
Raymond James	Nov 12, 2025	Downgrade	Strong Buy → Market Perform	—	70%
Keefe, Bruyette & Woods	Nov 7, 2025	Maintains	Market Perform	$50.00 → $70.00	71%

The case for and against

Updated Jul 31, 2025

Bull case

Brighthouse Financial Inc has demonstrated a positive outlook due to the overall improvement in the life insurance industry, which has seen reduced liability tail risk and enhanced returns alongside free cash flow conversion. The company's recent strategic actions, including a successful third-party reinsurance transaction that bolstered capital ratios and the expectation of mid-single-digit normalized earnings growth, further strengthen its financial position. Additionally, projected stability in the risk-based capital (RBC) ratio and positive statutory earnings support a constructive long-term growth trajectory for Brighthouse Financial.

Bear case

Brighthouse Financial Inc. currently faces significant financial challenges, notably its high debt levels of $4.9 billion in relation to its statutory profitability, which raises concerns about its financial stability. The company's free cash flow for 2024 is projected to be negatively impacted, with estimates suggesting a decline of over $1 billion, while earnings per share (EPS) projections for 2025 and 2026 have been reduced, indicating weakened expectations for profitability. Given these factors, alongside the prospect of continued struggles with capital ratios in a higher interest rate environment, the company presents a considerable downside risk with potential stock valuation drop to around $40.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.